» Articles » PMID: 24794098

Cardiac Sympathetic Denervation Without Lewy Bodies in a Case of Multiple System Atrophy

Overview
Specialty Neurology
Date 2014 May 6
PMID 24794098
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies.

Goldstein D, Sullivan P, Holmes C Clin Auton Res. 2024; .

PMID: 39656385 DOI: 10.1007/s10286-024-01093-6.


Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.

Carli G, Kanel P, Roytman S, Pongmala C, Albin R, Raffel D Eur J Nucl Med Mol Imaging. 2024; 51(13):3978-3989.

PMID: 38958681 PMC: 11897926. DOI: 10.1007/s00259-024-06822-7.


Cardiac F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure.

Lenka A, Isonaka R, Holmes C, Goldstein D Clin Auton Res. 2023; 33(6):737-747.

PMID: 37843677 DOI: 10.1007/s10286-023-00987-1.


Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Goldstein D, Isonaka R, Lamotte G, Kaufmann H Clin Auton Res. 2021; 31(6):677-684.

PMID: 34669076 PMC: 10680053. DOI: 10.1007/s10286-021-00829-y.


Cardiac F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA.

Lenka A, Lamotte G, Goldstein D Mov Disord Clin Pract. 2021; 8(4):582-586.

PMID: 33981791 PMC: 8088110. DOI: 10.1002/mdc3.13190.


References
1.
Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A . Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2006; 113(1):81-6. DOI: 10.1007/s00401-006-0160-y. View

2.
Raffel D, Koeppe R, Little R, Wang C, Liu S, Junck L . PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med. 2006; 47(11):1769-77. View

3.
Goldstein D, Orimo S . Cardiac sympathetic neuroimaging: summary of the First International Symposium. Clin Auton Res. 2009; 19(3):137-48. PMC: 2963152. DOI: 10.1007/s10286-009-0002-9. View

4.
Goldstein D, Sullivan P, Holmes C, Miller G, Alter S, Strong R . Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. J Neurochem. 2013; 126(5):591-603. PMC: 4096629. DOI: 10.1111/jnc.12345. View

5.
Goldstein D, Holmes C, Sharabi Y . Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Brain. 2012; 135(Pt 6):1900-13. PMC: 3359749. DOI: 10.1093/brain/aws055. View